Roger Stupp

Roger Stupp led the landmark EF-14 trial that established tumor treating fields (TTFields) plus temozolomide as a standard of care for newly diagnosed glioblastoma, demonstrating significant overall survival improvement. His work transformed TTFields from a novel concept into an FDA-approved treatment modality used worldwide. He continues to lead clinical trials expanding TTFields applications to other cancer types.